Norepinephrine to Prevent Hypotension in Ceasrean Delivery

• Status: Recruiting
• Trial end date: 2022-04-20
• Target enrollment: 0
• Participant gender: Female

Summary

This study will be conducted on 40 healthy women having spinal anesthesia for elective cesarean delivery in the operating rooms at Menoufia university hospital.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Menoufia University
• Treatments: Norepinephrine

Criteria

Inclusion Criteria:

• ASA I & II

• Non laboring

• Normotensive

• Elective cesarean delivery under spinal anesthesia.

• Baseline systolic blood pressure 90-140 mm Hg

Exclusion Criteria:

• Known fetal abnormality.

• Preexisting or pregnancy-induced hypertension.

• Known cardiovascular or cerebrovascular disease.

• Thrombocytopenia, coagulopathy or any contraindication to spinal anesthesia.

• Weight <50 or >100 kg, height <140 or >180 cm.

• Inability or refusal to give informed consent